You are required to be logged in to access the full website
Click here if you have forgotten your username or password
Therapy Areas
7 March 2025 - Danish pharmaceutical company ALK-Abelló A/S (ALK) (CPH:ALK-B) said on Friday that it has received approval from Health Canada for its ACARIZAX tablet to treat children aged five to 11 with house dust mite-induced allergic rhini...
7 March 2025 - Kancera AB (Nasdaq First North Premier Growth Market:KAN), a developer of anti-inflammatory drugs in the field of cardiovascular diseases, said on Friday that it has signed a letter of intent with US biotech company Recardio Inc to exp...
7 March 2025 - US-based drug discovery and development company Bantam Pharmaceutical announced on Thursday that it is proceeding with a Phase 1 clinical trial evaluating BTM-3566 in relapsed/refractory mature B-cell lymphomas, based on a recent Clini...
7 March 2025 - Clinical-stage biotech company ImmunoGenesis announced on Thursday that the first patient has been dosed in its Phase 1/2 clinical trial of its hypoxia reversal agent IMGS-101 (evofosfamide) in combination with Balstilimab (anti-PD-1) ...
6 March 2025 - Clinical-stage pharmaceutical company Plus Therapeutics Inc (Nasdaq:PSTV) announced on Thursday that the US Food and Drug Administration (FDA) has granted Orphan Drug Designation (ODD) to Rhenium (186Re) Obisbemeda for treating leptome...
6 March 2025 - Medical technology company Sectra (STO:SECT-B) announced on Thursday that a US health system will expand its enterprise imaging solution with digital pathology.This addition aims to enhance diagnostic efficiency by enabling pathologist...
5 March 2025 - Biopharmaceutical companies Jazz Pharmaceuticals plc (Nasdaq:JAZZ) and Chimerix (Nasdaq:CMRX) on Wednesday announced a definitive agreement for Jazz to acquire Chimerix for USD8.55 per share in cash, totalling approximately USD935m.Thi...